Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve Inter alia, to consider, approve and take on record the Audited Financial Results (both standalone and consolidated) for the 4th quarter of FY 2023-24 and for the Financial year 2023-24 ended on March 31, 2024.

pdf

Sunil Healthcare Ltd.

06 May 2024

81.70

0.86%

Corp. Note

Sunil Healthcare Ltd - 537253 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Intimation regarding loss of share certificate u/r 39(3) of SEBI LODR

pdf

Sunil Healthcare Ltd.

22 Apr 2024

81.70

0.86%

Corp. Note

Sunil Healthcare Ltd - 537253 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanySunil Healthcare Ltd 2CIN NO.L24302DL1973PLC189662 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 267900728.00 4Highest Credit Rating during the previous FY CAREBBBNEGATIVESTABLEOUTLOOK 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: SATYENDU PATTNAIK Designation: COMPANY SECRETARY EmailId: cs@sunilhealthcare.com Name of the Chief Financial Officer: PAWAN RATHI Designation: CHIEF FINANCIAL OFFICER EmailId: cfo@sunilhealthcare.com Date: 22/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Sunil Healthcare Ltd.

13 Apr 2024

81.70

0.86%

Company Update

Sunil Healthcare Ltd - 537253 - Compliance Certificate In Terms Of Regulation 40(10) Of SEBI (Listing …

BSE India

Compliance Certificate in terms of Regulation 40(10) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 for the year ended 31st March 2024

pdf

Sunil Healthcare Ltd.

08 Apr 2024

81.70

0.86%

Company Update

Sunil Healthcare Ltd - 537253 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for 4th quarter ended on 31st March 2024 of FY 2023-24

pdf

Sunil Healthcare Ltd.

08 Apr 2024

81.70

0.86%

Company Update

Sunil Healthcare Ltd - 537253 - Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR) Regulations …

BSE India

Compliance Certificate under Regulation 7(3) of SEBI (LODR) Reguations, 2015 for the year ended 31st March 2024

pdf

Sunil Healthcare Ltd.

28 Mar 2024

81.70

0.86%

SAST

Sunil Healthcare Ltd - 537253 - Closure of Trading Window

BSE India

Trading Window of the Company shall remain close with effect from April 01, 2024 till 48 hours after declaration of Audited Financial Results for the 4th quarter/ Financial year 2023-24 ended on 31st March 2024.

pdf

Sunil Healthcare Ltd.

16 Feb 2024

81.70

0.86%

Company Update

Sunil Healthcare Ltd - 537253 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper clipping regarding publication of Un-audited financial results for 3rd quarter/9 months ended on 31st December, 2023 of the FY 2023-24

pdf

Is Sunil Healthcare Ltd. worth buying?

65 Votes:

Buy 64.62%

Sell 30.77%

Hold 4.62%